^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

mitomycin

Company:
Generic mfg.
Drug class:
DNA synthesis inhibitor
Related drugs:
6d
The Genetic and Molecular Analyses of Rare Candidate Germline BRIP1/FANCJ Variants Implicated in Hereditary Breast and Ovarian Cancers. (PubMed, Int J Mol Sci)
Of the five reported BRIP1 variants, p.Thr266Met, p.Pro696Leu and c.2990_2993delCAAA; p.Thr997ArgfsTer61, which were predicted to be damaging, conferred cellular sensitivity to mitomycin C and cisplatin unlike p.Ser139Ala and p.Ala406Ser. Collectively, our investigation implicates BRIP1 c.797C>T; p.Thr266Met, c.2087C>T; p.Pro696Leu and c.2990_2993delCAAA; p.Thr997ArgfsTer61 as deleterious variants in OC and BC.
Journal
|
BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1)
|
cisplatin • mitomycin
6d
Differential transcriptomic modulation by histone deacetylase inhibitor SAHA in LUAD and LUSC. (PubMed, Clin Epigenetics)
SAHA imposes a common anti-proliferative core but engages distinct lineage-conditioned risk modules in LUAD and LUSC-cell-cycle/migration-linked in LUAD and checkpoint/stress-linked in LUSC. These SAHA feature-sensing modules provide a mechanistic and clinically anchored framework for subtype-tailored HDAC-directed combinations and for future development of HDACi-aligned biomarkers in NSCLC.
Journal
|
KRAS (KRAS proto-oncogene GTPase) • PDGFRA (Platelet Derived Growth Factor Receptor Alpha) • ANXA5 (Annexin A5) • HDAC4 (Histone Deacetylase 4) • HDAC7 (Histone Deacetylase 7)
|
TP53 wild-type • NRAS Q61
|
Zolinza (vorinostat) • mitomycin
8d
Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer (clinicaltrials.gov)
P1/2, N=24, Active, not recruiting, University of Nebraska | Trial primary completion date: Dec 2025 --> Jul 2026
Trial primary completion date
|
5-fluorouracil • mitomycin • BMX-001
11d
Autophagy Plays a Suppressive Role in Bladder Tumor Formation in an Orthotopic Mouse Model and Bladder Cancer Patient Specimens. (PubMed, Kaohsiung J Med Sci)
Notably, amiodarone showed equivalent anti-tumor efficacy but with fewer side effects on the treated mice compared to the clinical anti-cancer drug Mitomycin C (MMC). Similarly, low autophagy is associated with a poor overall survival rate. Furthermore, repurposing amiodarone-induced autophagy accompanied by trivial side effects shows potential for the treatment of bladder cancer patients.
Preclinical • Journal
|
ATG5 (Autophagy Related 5)
|
mitomycin
17d
New P1 trial
|
mitomycin • Tomudex (raltitrexed)
21d
TAPI-1 Combined With Silicone Stents Alleviated Severe Traumatic Tracheal Stenosis via the ADAM17/TGF-β1 Pathway. (PubMed, Can Respir J)
Tracheal epithelial cells were stimulated with GM-CSF and then treated after 24 h by lentivirus-mediated ADAM17 RNAi and mitomycin C. A model of severe traumatic tracheal stenosis was established in Beagle dogs...In conclusion, it was showed that TAPI-1 combined with silicone stents can significantly alleviate severe traumatic tracheal stenosis in Beagle dogs by inhibiting the ADAM17/TGF-β1 signaling pathway and expanding the narrowed trachea. TAPI-1 combined with silicone stents can be considered as a novel therapeutic approach for treating severe tracheal stenosis after trauma.
Journal
|
EGFR (Epidermal growth factor receptor) • TNFA (Tumor Necrosis Factor-Alpha) • CSF2 (Colony stimulating factor 2) • TGFB1 (Transforming Growth Factor Beta 1) • ADAM17 (ADAM Metallopeptidase Domain 17) • NECTIN1 (Nectin Cell Adhesion Molecule 1)
|
mitomycin
28d
Targeting the DNA damage response prevents regrowth of colorectal peritoneal metastasis-derived organoids following treatment with mitomycin C. (PubMed, Br J Cancer)
PMDOs can be completely eradicated if MMC treatment is followed by inhibition of ATR or other DDR kinases. DDR inhibitors may therefore have value in the adjuvant treatment of peritoneal metastases following CRS-HIPEC.
Journal
|
CHEK1 (Checkpoint kinase 1)
|
oxaliplatin • adavosertib (AZD1775) • irinotecan • berzosertib (M6620) • ceralasertib (AZD6738) • elimusertib (BAY 1895344) • mitomycin • rabusertib (LY 2603618)
1m
Stem Cell-Related Gene CALR as a Novel Prognostic Factor for Bladder Cancer: Implications for Immunotherapy. (PubMed, Hum Mutat)
Additionally, the study explored the correlation between CALR and immune cell infiltration, as well as its interaction with mitomycin using molecular docking methods...Laboratory investigations have demonstrated that reducing CALR expression can lessen the stemness features of BLCA. Our results highlight the critical role of genes related to stem cells in BLCA and identify CALR as a promising target associated with stem cell functionality.
Journal • IO biomarker • CALR
|
CALR (Calreticulin)
|
mitomycin
2ms
REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation (clinicaltrials.gov)
P2/3, N=33, Active, not recruiting, University of Cincinnati | Recruiting --> Active, not recruiting
Enrollment closed
|
capecitabine • mitomycin
2ms
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis (clinicaltrials.gov)
P2, N=40, Recruiting, Mayo Clinic | Trial completion date: May 2027 --> Jul 2029 | Trial primary completion date: May 2026 --> Jul 2029
Trial completion date • Trial primary completion date
|
KRAS (KRAS proto-oncogene GTPase)
|
cisplatin • albumin-bound paclitaxel • mitomycin
2ms
Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in 92 Patients with Peritoneal Metastases from Appendiceal Goblet Cell Adenocarcinoma. (PubMed, Ann Surg Oncol)
CRS and HIPEC provide 14% 5-year survival for GCA with peritoneal metastases. Complete cytoreduction, especially with PCI < 20, improves outcomes.
Journal
|
MUC16 (Mucin 16, Cell Surface Associated)
|
mitomycin